ELV Quote, Financials, Valuation and Earnings

Clover Health Investments has a net margin of 4.47% compared to Elevance Health's net margin of -0.28%. Elevance Health's return on equity of 14.03% beat Clover Health Investments's return on equity of -7.67%.

Elevance Health has a consensus price target of $503.49, signalling upside risk potential of 33.22%. On the other hand Clover Health Investments has an analysts' consensus of $4.69 which suggests that it could grow by 49.76%. Given that Clover Health Investments has higher upside potential than Elevance Health, analysts believe Clover Health Investments is more attractive than Elevance Health.

Elevance Health has a beta of 0.657, which suggesting that the stock is 34.296% less volatile than S&P 500. In comparison Clover Health Investments has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.75%. Clover Health Investments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Clover Health Investments pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $48.9B, which are larger than Clover Health Investments quarterly revenues of $462.3M. Elevance Health's net income of $2.2B is higher than Clover Health Investments's net income of -$1.3M. Notably, Elevance Health's price-to-earnings ratio is 14.75x while Clover Health Investments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.48x versus 1.04x for Clover Health Investments. Usually stocks with elevated PS ratios are considered overvalued.

Centene has a net margin of 4.47% compared to Elevance Health's net margin of 2.81%. Elevance Health's return on equity of 14.03% beat Centene's return on equity of 12.65%.

Elevance Health has a consensus price target of $503.49, signalling upside risk potential of 33.22%. On the other hand Centene has an analysts' consensus of $78.09 which suggests that it could grow by 39.63%. Given that Centene has higher upside potential than Elevance Health, analysts believe Centene is more attractive than Elevance Health.

Elevance Health has a beta of 0.657, which suggesting that the stock is 34.296% less volatile than S&P 500. In comparison Centene has a beta of 0.478, suggesting its less volatile than the S&P 500 by 52.18%.

Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.75%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $48.9B, which are larger than Centene quarterly revenues of $46.6B. Elevance Health's net income of $2.2B is higher than Centene's net income of $1.3B. Notably, Elevance Health's price-to-earnings ratio is 14.75x while Centene's PE ratio is 8.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.48x versus 0.17x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of 4.47% compared to Elevance Health's net margin of 2.67%. Elevance Health's return on equity of 14.03% beat Molina Healthcare's return on equity of 25.66%.

Elevance Health has a consensus price target of $503.49, signalling upside risk potential of 33.22%. On the other hand Molina Healthcare has an analysts' consensus of $360.24 which suggests that it could grow by 19.55%. Given that Elevance Health has higher upside potential than Molina Healthcare, analysts believe Elevance Health is more attractive than Molina Healthcare.

Elevance Health has a beta of 0.657, which suggesting that the stock is 34.296% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.702%.

Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.75%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health pays 25.22% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $48.9B, which are larger than Molina Healthcare quarterly revenues of $11.1B. Elevance Health's net income of $2.2B is higher than Molina Healthcare's net income of $298M. Notably, Elevance Health's price-to-earnings ratio is 14.75x while Molina Healthcare's PE ratio is 14.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.48x versus 0.41x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 4.47% compared to Elevance Health's net margin of 5.74%. Elevance Health's return on equity of 14.03% beat UnitedHealth Group's return on equity of 21.74%.

Elevance Health has a consensus price target of $503.49, signalling upside risk potential of 33.22%. On the other hand UnitedHealth Group has an analysts' consensus of $397.36 which suggests that it could grow by 33.3%. Given that UnitedHealth Group has higher upside potential than Elevance Health, analysts believe UnitedHealth Group is more attractive than Elevance Health.

Elevance Health has a beta of 0.657, which suggesting that the stock is 34.296% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.561, suggesting its less volatile than the S&P 500 by 43.865%.

Elevance Health has a quarterly dividend of $1.71 per share corresponding to a yield of 1.75%. UnitedHealth Group offers a yield of 2.82% to investors and pays a quarterly dividend of $2.10 per share. Elevance Health pays 25.22% of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health quarterly revenues are $48.9B, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. Elevance Health's net income of $2.2B is lower than UnitedHealth Group's net income of $6.3B. Notably, Elevance Health's price-to-earnings ratio is 14.75x while UnitedHealth Group's PE ratio is 12.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health is 0.48x versus 0.67x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.